Desai’s drug delivery research focus of agreement between UCSF and Zcube

Drug delivery research led by UCSF’s Tejal Desai, PhD, will now be supported by an exclusive worldwide license agreement between UCSF and Zcube s.r.l. The agreement focuses on drug delivery micro patches, developed by Desai, which stick to the lining of the intestine where they release their precise medication payloads directly into the intestinal lining and then into the bloodstream. The packets reduce the amount of medication required in each dose while increasing the amount of medication that reaches the bloodstream. Desai is a faculty member in the UCSF Department of Bioengineering and Therapeutic Sciences. Zcube s.r.l. is the research corporate venture arm of Italian pharmaceutical leader Zambon Co., S.p.A.


UCSF Collaborates with Zcube to Develop New Ways to Deliver Drugs

About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.